TNFSF13B and metabolic dysfunction-associated steatotic liver disease: In our preliminary study, we measured serum BAFF concentrations in patients with histologically diagnosed NAFLD (n = 65) and found that the prevalence of severe steatosis (>66%) was significantly higher among patients with higher BAFF concentrations than among those with lower BAFF concentrations (data not shown).